 Adverse experience methotrexate weeks longterm prospective trial patients rheumatoid arthritis Adverse experience high frequency longterm years prospective double blind open trial methotrexate MTX therapy patients rheumatoid arthritis RA Adverse experiences patients discontinuation rate weeks No hepatic pulmonary fibrosis Unusual toxicities weight loss patients systemic fungal infections patients transient noncirrhotic ascites patient Baseline white blood cell counts creatinine adverse experiences full dose-toxicity spectrum MTX RA